CARGO Therapeutics Inc (NASDAQ:CRGX) currently has a daily average trading volume of 1.26M but it saw 745830 shares traded in last market. With a market cap of 211.84M USD, the company’s current market price of $4.55 came falling about -1.09 while comparing to the previous closing price of $4.60. In past 52 weeks, the stock remained buoying in the range of price level as high as $25.45 and as low as $3.00. In the recent trading on the day, stock has struck highest price mark of $4.54 while lowest mark touched by it was $4.77.
Taking a look at 20-day trading activity of CARGO Therapeutics Inc (CRGX) gives us an average price of $4.26, while its current price level is -82.12% below from 52-week high level whereas it is 51.67% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $4.04 while that of 200 days or SMA-200 reads an average of $13.57. A closer look into the stock’s movement over the week reveals that its volatility is standing at 4.39% during that period while stretching the period over a month that increases to 5.77%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 55.65 which implies that the stock is in neutral territory.
Truist downgraded its recommendation for the stock as a “Hold” from “Buy” on January 30, 2025 while assigning a price target range of $32-$7. Piper Sandler also issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $34 and $4.
Year-to-date it is -68.45% down and over the past year, the stock is showing a downside performance of -76.29%.
The company is expected to be releasing its next quarterly report on 2025-Mar-11, for which analysts forecasted an EPS of -0.57 while estimate for next year EPS is -1.96.
Currently, CARGO Therapeutics Inc’s total number of outstanding shares is 46.04M with 1.13% of that held by the insiders while 122.71% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -43.06% and return on equity (ROE) at -43.76%. Stock’s beta reads 0.02. Stock has a price to book (P/B) ratio of 0.58. Its return on asset (ROA) is -38.64% on average.
